TGen receives $2.5 million SU2C grant for new pancreatic cancer clinical trial

Posted on Thu/12/OctoberThu/12/October by AZBio

Investigation with Salk and Mayo Clinic headed by TGen’s Dr. Von Hoff is one of 10 ‘SU2C Catalyst’ studies using powerful new approachesContinue reading→

Video Gallery Celebrating our 2017 AZBio Awards Winners

Posted on Thu/12/OctoberThu/12/October by AZBio

On October 11, 2017, we celebrated the AZBio Awards. We invite you to watch the videos to learn more about our AZBio Awards Honorees. Continue reading→

TGen sequencing test enables precise identification of drug-resistant TB

Posted on Mon/9/OctoberMon/9/October by AZBio

UCSF and TGen researchers advance SMOR testing, with an eye on precision medicine for tuberculosisContinue reading→

AZBio In The Loop – AZBW 2017 Edition

Posted on Mon/9/OctoberSun/10/June by AZBio

Continue reading→

Bard Peripheral Vascular named Arizona Bioscience Company of the Year

Posted on Mon/9/OctoberMon/9/October by AZBio

Bard Peripheral Vascular, a division of C. R. Bard, will be honored for Advancing Lives and the Delivery of Health Care Worldwide at the 2017 AZBio Awards on Oct. 11, 2017.Continue reading→

Funded by $21.4 million grant, new NAU research center will address health disparities across Southwest

Posted on Fri/6/OctoberFri/6/October by AZBio

NAU professor Julie Baldwin, director of the Center for Health Equity Research, and Diane Stearns, NAU associate vice president for research, will co-lead the Southwest Health Equity Research Collaborative.

Continue reading→

Ventana Medical Systems Founder Dr. Tom Grogan takes on new role as Founder Emeritus

Posted on Thu/5/OctoberThu/5/October by AZBio

Dr. Tom Grogan set out on a path to change the practice of medicine 32 years ago when he founded Ventana Medical Systems, Inc., now a global leader in cancer diagnostics that was acquired by Swiss-based Roche Group in 2008. Continue reading→

AZBio In The Loop for the week of Oct. 2, 2017

Posted on Mon/2/OctoberSun/10/June by AZBio

Continue reading→

AZBW 2017 Puts Arizona Life Science Innovation In The Spotlight

Posted on Sun/1/OctoberMon/2/October by AZBio

Arizona Bioscience Week Connects Community and Celebrates One of the Fastest Growing Life Science and Healthcare Sectors in the United States.Continue reading→

National Cancer Institute Awards Grant to NuvOx Pharma for Phase II Clinical Trial in Brain Cancer

Posted on Fri/29/SeptemberFri/29/September by AZBio

The National Institutes of Health’s National Cancer Institute (NCI) has awarded a grant for up to $3 million to NuvOx Pharma to initiate a Phase II clinical trial for the investigational drug, NVX-108, in the brain cancer, glioblastoma multiforme (GBM).Continue reading→